Suppr超能文献

选择性(β1)与非选择性(β1和β2)β-肾上腺素能阻滞剂对心绞痛患者全身及冠状动脉血流动力学影响的比较。

Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.

作者信息

Prida X E, Feldman R L, Hill J A, Pepine C J

出版信息

Am J Cardiol. 1987 Aug 1;60(4):244-8. doi: 10.1016/0002-9149(87)90221-9.

Abstract

To investigate the influence of selective beta 1-adrenergic blockade, in contrast to beta 1- and beta 2-adrenergic blockade, systemic and coronary hemodynamics were studied. Measurements were made at rest and during exercise in 23 patients with suspected coronary artery disease (CAD) before and after either metoprolol or propranolol, given in doses to provide comparable beta 1-receptor blockade. Quantitative coronary angiography was performed at rest. Using a randomized, double-blind protocol, either beta 1 and beta 2 blockade was produced by propranolol (0.1 mg/kg intravenously), or selective beta 1 blockade was produced by metoprolol (0.15 mg/kg intravenously). As expected, at these doses both drugs produced a comparable decrease in heart rate at rest and during exercise, averaging 9% and 14% after propranolol and 10% and 16% after metoprolol. Exercise duration to ischemia was prolonged in most patients with severe CAD after either propranolol (5 of 7) or metoprolol (6 of 10) treatment. The effects of these 2 beta-blocking drugs on systemic hemodynamic values at rest and during exercise were similar. Additionally, coronary sinus flow was usually unchanged by both drugs at rest (-5% after propranolol and -4% after metoprolol, differences not significant) and decreased a similar amount during exercise (-15% after propranolol and -9% after metoprolol, both p less than 0.05). Coronary resistance did not change significantly with either drug (0% after propranolol and 3% after metoprolol), and during exercise (11% after propranolol and 3% after metoprolol), suggesting that decreases in flow were secondary to reduced demand. Furthermore, neither drug produced detectable changes in coronary artery size.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为研究选择性β1肾上腺素能阻滞(与β1和β2肾上腺素能阻滞相比)对全身和冠状动脉血流动力学的影响,我们进行了相关研究。对23例疑似冠心病(CAD)患者在静息和运动状态下,分别于服用美托洛尔或普萘洛尔前后进行测量,给予的药物剂量能提供相当的β1受体阻滞作用。静息状态下进行定量冠状动脉造影。采用随机双盲方案,普萘洛尔(静脉注射0.1mg/kg)产生β1和β2阻滞,美托洛尔(静脉注射0.15mg/kg)产生选择性β1阻滞。正如预期,在这些剂量下,两种药物在静息和运动时均使心率出现相当程度的下降,普萘洛尔后平均下降9%和14%,美托洛尔后平均下降10%和16%。在大多数重度CAD患者中,普萘洛尔(7例中的5例)或美托洛尔(10例中的6例)治疗后,缺血性运动持续时间延长。这两种β受体阻滞剂对静息和运动时全身血流动力学值的影响相似。此外,两种药物在静息时通常对冠状窦血流无影响(普萘洛尔后为-5%,美托洛尔后为-4%,差异无统计学意义),运动时均下降相似幅度(普萘洛尔后为-15%,美托洛尔后为-9%,P均小于0.05)。两种药物对冠状动脉阻力均无显著影响(普萘洛尔后为0%,美托洛尔后为3%),运动时也如此(普萘洛尔后为11%,美托洛尔后为3%),提示血流减少是需求降低所致。此外,两种药物均未引起冠状动脉大小的可检测变化。(摘要截选至250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验